Patents Assigned to YouHealth Oncotech, Limited
  • Breast and ovarian cancer methylation markers and uses thereof
    Patent number: 11396678
    Abstract: Disclosed herein are methods and kits for identifying a subject as having breast cancer. Also provided herein are methods and kits for determining the prognosis of a subject having breast cancer and for determining the progression of breast cancer in a subject.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: July 26, 2022
    Assignees: The Regent of the University of California, YouHealth Oncotech, Limited
    Inventors: Kang Zhang, Rui Hou, Lianghong Zheng
  • Leukemia methylation markers and uses thereof
    Patent number: 10829821
    Abstract: Disclosed herein are methods and kits for identifying a subject as having leukemia. Also provided herein are methods and kits for determining a leukemia subtype in subject. Further provided herein are methods and kits for determining the prognosis of a subject having leukemia and for determining the progression of leukemia in a subject.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: November 10, 2020
    Assignees: YOUHEALTH ONCOTECH, LIMITED, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Kang Zhang, Rui Hou, Lianghong Zheng
  • METHYLATION MARKERS FOR DIAGNOSING CANCER
    Publication number: 20200277677
    Abstract: Disclosed herein are methods, probes, and kits for diagnosing the presence of cancer and/or a cancer type in a subject.
    Type: Application
    Filed: October 5, 2018
    Publication date: September 3, 2020
    Applicants: YouHealth Oncotech, Limited, The Regents of the University of California
    Inventors: Kang ZHANG, Rui HOU, Lianghong ZHENG, Gen LI
  • Solid tumor methylation markers and uses thereof
    Patent number: 10544467
    Abstract: Disclosed herein are methods and kits for identifying a subject as having esophagus cancer, pancreatic cancer, or stomach cancer. Also provided herein are methods and kits for generating the methylation profile of a biomarker associated with esophagus cancer, pancreatic cancer, or stomach cancer.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: January 28, 2020
    Assignees: YouHealth Oncotech, Limited, The Regents of the University of California
    Inventors: Kang Zhang, Rui Hou, Lianghong Zheng
  • Methylation markers for diagnosing hepatocellular carcinoma and lung cancer
    Patent number: 10513739
    Abstract: Disclosed herein, in certain embodiments, are methods and kits for diagnosing a subject as having hepatocellular carcinoma (HCC) or lung cancer. In some instances, also described herein are methods of determining the prognosis of the subject having HCC or lung cancer. In additional instances, described herein are methods of determining the specific staging of HCC or lung cancer in a subject.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: December 24, 2019
    Assignees: YouHealth Oncotech, Limited, The Regents of the University of California
    Inventors: Kang Zhang, Rui Hou, Lianghong Zheng